Thiếu máu do thiếu sắt

Rising Burden of Anemia and Iron Deficiency Among U.S. Nonpregnant Women of Reproductive Age: Insights from NHANES 1999–2023

By MedXY 08/18/2026

Analysis of NHANES data reveals increasing anemia and iron deficiency anemia rates among nonpregnant U.S. women aged 20-45 from 1999 to 2023, with persistently high iron deficiency prevalence.

Hematology-Oncology news OB/GYN & Women’s Health

Hematologic Response to Iron Therapy and Stillbirth Risk in Moderate Iron Deficiency Anemia

By MedXY 05/08/2026

Study reveals inadequate hemoglobin improvement at 20-24 weeks after iron therapy increases stillbirth and preterm birth risks in moderate iron deficiency anemia pregnancies, highlighting need for early intervention.

Clinical Updates news OB/GYN & Women's Health

The Rising Burden of Anemia in Pregnancy: Epidemiological Trends, Clinical Impact, and Evolving Management Strategies

By MedXY 04/02/2026

This review synthesizes recent evidence on pregnancy-related anemia, highlighting a 25.6% US prevalence, the clinical significance of iron deficiency without anemia (IDWA), and the critical impact on maternal-fetal outcomes and cardiovascular health.

Clinical Updates news OB/GYN & Women's Health

Optimizing Iron Deficiency Management in Pregnancy: A Synthesis of Evidence for Intravenous Ferumoxytol vs. Oral Ferrous Sulfate

By MedXY 03/20/2026

This clinical review evaluates the superior efficacy of intravenous ferumoxytol over oral iron for treating gestational anemia, analyzing hematologic recovery and maternal outcomes based on the latest RCT evidence.